National and Kapodistrian University of Athens
Σχεδιασμός και σύνθεση νέων λιπόφιλων χηλικών παραγόντων με αντιική και αντιπαρασιτική δράση
Abstract
dc:descriptionThe present PhD thesis describes the design and synthesis of new molecules that bear a bidental metal binding functional group, which can act as potent metalloenzyme inhibitors with antiparasitic and antiviral activity. The description of the present work is divided into two parts. The first part comprises of a series of hydantoin analogues which are substituted with the carbohydroxamic acid group, and they exhibit activity against the flagellate parasites T. brucei and T. cruzi. The design of these compounds was based on previous studies and publications of our research group, which showed that the introduction of the acetohydroxamic acid moiety on the imide nitrogen atom of lipophilic spirocarbocyclic 2,6-dicetipeperazines, leads to derivatives that have significant trypanocidal activity. In detail, acetohydroxamic acids bearing an ethyl or a benzyl group on the amide nitrogen atom of the hydantoin ring, acetohydroxamic acids, incorporated into the N1-alicyclic/aryl hydantoin ring, N-hydroxypropanamidic compounds and glycine hydroxamate analogues were synthesized. Considering the approach to further exploit metal ion complexing properties of compounds against more than one microorganism and the fact that several metal chelating agents with anti-HCV activity have been reported in the literature, the new synthetic analogues were tested for their effect on HCV RNA replication and other re-emerging Flaviviruses, within the Flaviviridae family. The new analogues exhibited antitrypanosomal potency against T. brucei with EC50 values, ranging from 8 nM to 31.8 μM and remarkable selectivity indices. Furthermore, most compounds display activity in nanomolar to micromolar range against two different HCV subgenomic replicons, and some of them are active against one or more Flaviviruses. The second part includes the synthesis of a series of N-hydroxypyridinediones (HPDs), described as HBV RNaseH inhibitors. The concept derived from the ability of certain compounds, which bear the N-hydroxyimidic moiety to inhibit HBV replication. In this way, HPDs conjugated to arylamines, arylalkylamines and hydroxylamines were synthesized, which preferentially suppress the synthesis of plus-polarity DNA strand in HBV replicating cells. Twenty-two compounds were tested for their activity against HBV replication in culture, and twenty of them proved active, possessing submicromolar to low micromolar EC50 values. By synthesizing these new HPDs, an improvement in the therapeutic index of the lead compound was achieved, with no simultaneous suppression of the human enzyme, huRNaseH1.
Degree
thesis:*- Grantor dc:publisher
- National and Kapodistrian University of Athens
- Year dc:date
- 2021
Author and committee
dc:creator, dc:contributor.*- Authors dc:creator
-
- Pardali, Vasiliki
- Παρδάλη, Βασιλική
Subjects
dc:subject × 18- Ανθρώπινη αφρικανική τρυπανοσωμίαση
- Αμερικανική τρυπανοσωμίαση
- Ηπατίτιδα Β
- Ηπατίτιδα C
- Χηλικοί παράγοντες
- Υδροξαμικά οξέα
- Human african trypanosomiasis
- American trypanosomiasis
- Hepatitis B
- Hepatitis C
- Metal chelating agents
- Hydroxamic acids
- Επιστήμες Υγείας
- Ιατρική και Επιστήμες Υγείας
- Επιστήμες υγείας, γενικά
- Health Sciences
- Medical and Health Sciences
- Health sciences, general
Rights
- Language dc:language
- gre
Identifiers
dc:identifier.*- Identifier
- 10.12681/eadd/50697